LOS ANGELES, July 21, 2017 -- Lundin Law PC, a shareholder rights firm, announces the filing of a class action lawsuit against DryShips Inc. (“DryShips” or the “Company”) (Nasdaq:DRYS) concerning possible violations of federal securities laws between June 8, 2016 and July 12, 2017 inclusive (the “Class Period”). Investors who purchased or otherwise acquired shares during the Class Period should contact the firm prior to the September 12, 2017 lead plaintiff motion deadline.
To participate in this class action lawsuit, click here.
You can also call Brian Lundin, Esq., of Lundin Law PC, at 888-713-1033, or you can e-mail him at [email protected].
No class has been certified in the above action yet. Until a class is certified, you are not considered represented by an attorney. You may also choose to do nothing and be an absent class member.
According to the Complaint, throughout the Class Period, DryShips made materially false and/or misleading statements, and/or failed to disclose: that the Company engaged in a systemic stock-manipulation scheme to artificially inflate its share price; that DryShips’ transactions with Kalani Investments Ltd. were an illegal capital-raising scheme, due partly to Kalani’s failure to register as an underwriter with the U.S. Securities and Exchange Commission; and that as a result of the above, the Company’s public statements were materially false and misleading at all relevant times. Since November 2016, DryShips’ stock price has fallen about 99%, which caused investors harm according to the Complaint.
Lundin Law PC was founded by Brian Lundin, Esq., a securities litigator based in Los Angeles dedicated to upholding shareholders’ rights.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
Contact: Lundin Law PC Brian Lundin, Esq. Telephone: 888-713-1033 Facsimile: 888-713-1125 [email protected] http://lundinlawpc.com/


JPMorgan’s Top Large-Cap Pharma Stocks to Watch in 2026
Warner Bros Discovery Weighs Amended Paramount Skydance Bid as Netflix Takeover Battle Intensifies
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
GLP-1 Weight Loss Pills Set to Reshape Food and Fast-Food Industry in 2025
Waymo Plans Safety and Emergency Response Upgrades After San Francisco Robotaxi Disruptions
Moore Threads Unveils New GPUs, Fuels Optimism Around China’s AI Chip Ambitions
BP Nears $10 Billion Castrol Stake Sale to Stonepeak
ByteDance Plans Massive AI Investment in 2026 to Close Gap With U.S. Tech Giants
Texas App Store Age Verification Law Blocked by Federal Judge in First Amendment Ruling
Nvidia to Acquire Groq in $20 Billion Deal to Boost AI Chip Dominance
Uber and Baidu Partner to Test Robotaxis in the UK, Marking a New Milestone for Autonomous Ride-Hailing
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccine Portfolio
Nike Stock Jumps After Apple CEO Tim Cook Buys $2.9M Worth of Shares
Boeing Wins $2.04B U.S. Air Force Contract for B-52 Engine Replacement Program
Niigata Set to Approve Restart of Japan’s Largest Nuclear Power Plant in Major Energy Shift
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss 



